A standard daily multivitamin, the kind sold at every pharmacy for roughly a dime a dose, slowed biological aging across ...

PREDICT-1 is the first genotype-based registrational trial in dry eye disease (DED), with the potential of delivering a first-in-class precision medicine treatment in DEDThis FDA-aligned trial targets ...

Peer-reviewed randomized controlled trial of 427 adults found that after completing Noom’s 16-week program, members continued ...

Actuate Therapeutics, Inc. (NASDAQ: ACTU), a clinical-stage biopharmaceutical company focused on developing novel therapies for difficult-to-treat cancers, today announced that elraglusib will be ...

Malaria control and elimination is threatened by the spread of insecticide resistance and behavioral adaptation of vectors. Whether mass administration of ivermectin, a broad-spectrum antiparasitic ...

MCID in their MG-ADL with a mean >4 point improvement in MG-ADL observed in Phase 1 study of Subcutaneous BRIUMVI in patients with MG (n=11) ...

A thought experiment in prevention: What if dogs do more for cardiovascular health than statins? Let’s examine the data, ...

At least 12 of my colleagues boarded planes to the American Society of Clinical Oncology conference in Chicago last week to ...

Primary analyses showed no significant differences between the semaglutide and placebo groups in laboratory measures of ...

Idiopathic normal-pressure hydrocephalus is a neurologic disorder characterized by impaired gait, balance, cognition, and bladder control in older adults. The disorder is treated with shunt surgery, ...

But phase III study testing selinexor plus ruxolitinib splits on its main goals ...